Loading
Delivra Health Brands Inc. Stock: price and insider trades · Canada
CA·Mcap CA$2.7M
Delivra Health Brands Inc.: what insiders have been doing
This page follows insider dealings at Delivra Health Brands Inc. as filed with SEDI. From 18 October 2025 to 18 October 2026, the disclosure feed for Delivra Health Brands Inc. logged 11 filings by 2 insiders.
The flow runs one way only: 2 insiders bought (10 purchases totalling €6,474) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives. At €1,802, the purchase published on 15 June 2026 by Davey, Gord is the largest of the period.
The latest purchase dates back some time: it was published 36 days ago, on 11 September 2026. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade.
Across the 2,120 companies tracked on its exchange, the median is 12 filings; at 11 filings, this issuer sits below that mark. Looking back to 2026, when coverage begins, insiders filed 10 purchases and no sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€6,474
10 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleGord Davey9 buys
John Barrett1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 2,012 of 24,166 companies
75.3
score / 100
Value97
Quality53
FCF yld25%
Earn yld29%
EV/EBITDA2.1x
ROE-28%
Gross mgn52%
Net mgn7.1%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
CA$0.09
Analyst consensus
1 analysts1.00/5
CA$0.53Target CA$0.53(+524%)CA$0.53
Income statement
RevenueCA$12.4M
Gross profitCA$6.4M52% margin
EBITDACA$2.4M19% margin
Net incomeCA$876k-9.0% margin
Valuation
PER (forward)-2.7x
P/Book0.9x
Beta0.88
Balance sheet & cash
Market capCA$2.7M
Total debtCA$2M
Free Cash FlowCA$756k
Debt / Equity79%
Profitability & ownership
ROE-28.3%
ROA-7.6%
% insiders11.9%
% institutions0.0%
Last declaration on 11 September 2026
Declarations11 total
10,000 shares@ CA$0.08150.028% mcap100.0% of flowCommon SharesTSXSEDI:4776654
Canonical exit: 9 Dec 2026 (T+90)
Common SharesTSXSEDI:4776653
26,500 shares@ CA$0.1130.2% of flowCommon SharesTSXSEDI:4735852
Canonical exit: 10 Sept 2026 (T+90)
22,000 shares@ CA$0.1022.8% of flowCommon SharesTSXSEDI:4735851
Canonical exit: 10 Sept 2026 (T+90)
13,000 shares@ CA$0.1216.2% of flowCommon SharesTSXSEDI:4735850
Canonical exit: 10 Sept 2026 (T+90)
8,000 shares@ CA$0.129.9% of flowCommon SharesTSXSEDI:4735849
Canonical exit: 10 Sept 2026 (T+90)
6,000 shares@ CA$0.116.8% of flowCommon SharesTSXSEDI:4735848
Canonical exit: 10 Sept 2026 (T+90)
5,000 shares@ CA$0.126.2% of flowCommon SharesTSXSEDI:4735847
Canonical exit: 10 Sept 2026 (T+90)
3,500 shares@ CA$0.124.4% of flowCommon SharesTSXSEDI:4735846
Canonical exit: 10 Sept 2026 (T+90)
2,500 shares@ CA$0.112.8% of flowCommon SharesTSXSEDI:4735845
Canonical exit: 10 Sept 2026 (T+90)
500 shares@ CA$0.120.6% of flowCommon SharesTSXSEDI:4735844
Canonical exit: 10 Sept 2026 (T+90)
11 of 11 declarations
About Delivra Health Brands Inc.
Delivra Health Brands Inc. is a Canadian company focused on the development and marketing of natural health products. It is listed on the Toronto Stock Exchange under the symbol XTSE.
